The histopathological diagnosis was tubular 2, moderately differentiated cancer (Union for International Cancer Control classification, 7th edition) (16), and ERB-B2 receptor tyrosine kinase 2-negative, tubular, moderately differentiated cancer (the World Health Organization classification of 2019) (17). This evidence concerns the gene ERBB2 and cancer.